Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence - Wikidata - awgldk - TriplyDB

Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence

Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence

http://www.wikidata.org/entity/Q34769139

about

Association between urinary incontinence and depressive symptoms in overweight and obese women.Duloxetine for treatment of male sphincteric incontinence following partial conus medullaris infarction after coronary bypass surgery.Linking the evidence between urinary retention and antipsychotic or antidepressant drugs: A systematic review.Safety and adverse event profile of duloxetine.A review of the adverse effects and safety of noradrenergic antidepressants.Depression, Anxiety and the Bladder.Duloxetine in the treatment of stress urinary incontinence.Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial.Profile of sexual and genitourinary treatment-emergent adverse events associated with atomoxetine treatment: a pooled analysis.

P2860

Q30436188-6F9FCEBB-C4EE-49A7-9C88-D6616521D1BE Q33580284-0F272115-FE0C-4C30-B1E9-772CB2CD06A7 Q35750383-E8D13FF7-86A9-4872-AAE9-F19586EFE28B Q36299961-F6473F8D-1EF3-4202-B5D2-6516AFF0F187 Q38115737-66389EEC-BD32-462A-A2BF-C66C403B1490 Q38668369-D57C5138-111C-47F6-BDCB-4D637CBB594F Q43267071-3CAD87CB-3862-44B8-BDD9-7DC6D739612D Q46516264-8B538DA6-1B2C-42B0-BD33-0020D7765925 Q51233160-41AD9445-015D-4C60-9959-7E6840E2C769

P2860

Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence

http://www.wikidata.org/entity/Q34769139

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@ast

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@en

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@nl

type

label

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@ast

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@en

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@nl

prefLabel

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@ast

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@en

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@nl

P1433

Q34769139-3635212A-5CFD-40FF-91B3-12C5E0FB355B

P1476

Q34769139-6EDC5709-E0D8-4FBE-AE5D-B2F156D6A5BB

P2093

Q34769139-3308F63D-1C90-42AA-8949-16D43359FE6D

Q34769139-64BFEE4C-1220-4B6E-A03C-159880E8FE8D

Q34769139-7CBEE18B-E93E-4172-B5A6-A9574CA6C81F

Q34769139-A4631C25-6568-41AC-B76B-7F823B078C60

P2860

Q34769139-14CBEA1D-001C-41FC-A849-5F3532CCFF63

Q34769139-1C5B292B-4FF6-4BEB-8C48-5F40CF15B182

Q34769139-2120288A-A284-4A6F-BC71-796FE20E3CAF

Q34769139-274707D1-0985-4A57-B569-CC1F67EB7A99

Q34769139-328BC5FF-B13C-49C9-9D8C-0FA9DB6F38B2

Q34769139-3B5116D8-1FDF-437E-AA5A-DC0129507862

Q34769139-4024051E-4F97-4E44-96C5-871DEB2305E8

Q34769139-45034CC3-E292-481E-8035-0D3B42DB6A6A

Q34769139-613C76A9-9F17-46D0-B2B7-6DE81CCEE8BD

Q34769139-64FFD0D2-8675-4359-AA68-C44BD086D14C

P304

Q34769139-C2517997-BC55-4AEF-8680-2357120B3BF1

P31

Q34769139-D2C27F08-5197-4BCC-A938-17A8162EBD33

P356

Q34769139-FE5F6973-BFAC-48F8-BECC-4E35FDA0FB81

P433

Q34769139-3D002CB9-BE1A-4361-86F0-9D6E10B19C6E

P478

Q34769139-B9A4E394-C395-4169-A657-347B6809B8CF

P577

Q34769139-623F278F-4C7D-4271-85FB-8BA99F0204B8

P698

Q34769139-3E84F499-E0EC-40A3-B730-EB4F02B4B87F

P932

Q34769139-2AB76C04-2C40-4E45-B2FF-92033F63D64E

P356

P1433

Primary Care Companion to the Journal of Clinical Psychiatry

P1476

Urinary Side Effects of Duloxe ...... nd Stress Urinary Incontinence

@en

P2093

Beth A. Pangallo

http://www.w3.org/2001/XMLSchema#string

Lars Viktrup

http://www.w3.org/2001/XMLSchema#string

Michael J. Detke

http://www.w3.org/2001/XMLSchema#string

Norman R. Zinner

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results

Milnacipran. A review of its use in depression.

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

Tolterodine: a clinical review.

Dual monoamine modulation for improved treatment of major depressive disorder.

Pharmacological agents used for the treatment of stress urinary incontinence in women.

Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Serotonergic facilitation of facial motoneuron excitation.

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/PCC.V06N0204

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15254599

http://www.w3.org/2001/XMLSchema#string

P932

427601

http://www.w3.org/2001/XMLSchema#string